Shantha Biologics wins high-stakes Novo Nordisk fill-finish mandate in Hyderabad
Read how Shantha Biologics’ Novo Nordisk cartridge fill-finish deal could reshape complex injectable manufacturing in India.
Pharma & Biotech
Pharma & Biotech
Why Vetter’s Saarlouis expansion matters for sterile injectable supply chains
Injectable capacity is tightening. Vetter’s Saarlouis bet shows why Europe wants more control over sterile drug manufacturing.